<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US" lang="en-US">
<head>
  <title>Peter McCarthy - LinkedIn </title>
  <meta http-equiv="content-type" content="text/html; charset=UTF-8" />
  <link href="http://www.linkedin.com/favicon.ico" rel="shortcut icon" type="image/ico"></link>
    <meta name="description" content="View Peter McCarthy's professional profile on LinkedIn.  LinkedIn is the world's largest business network, helping professionals like Peter McCarthy discover inside connections to recommended job candidates, industry experts, and business partners." />
    
  
      <link rel="stylesheet" type="text/css" href="http://static.linkedin.com/scds/pprofile/build-499_4_2302-prod/css/public-profile/default.css">
    
</head>
<body id="www-linkedin-com" class="public-profile">

<script type="text/javascript">document.body.className += " js";</script>
  
<div class="hresume">
    <div class="profile-header">
      <div class="masthead vcard contact">
        <div id="nameplate">
          <h1 id="name"><span class="fn n"><span class="given-name">Peter</span> <span class="family-name">McCarthy</span></span></h1>
        </div>
        <div class="content">
          <div class="info">
              <p class="headline title">
                
      Energetic and succesful leader of discovery and exploratory development pharma organizations
    
              </p>
            <div class="adr">
              <p class="locality">
                
      New London/Norwich, Connecticut Area
    
              </p>
            </div>
          </div>
          <div class="actions">
            <ul>
              <li id="send-inmail">
                <a href="http://www.linkedin.com/ppl/webprofile?action=ctu&amp;id=12104394&amp;pvs=pp&amp;authToken=OCTl&amp;authType=name&amp;trk=ppro_cntdir&amp;lnk=cnt_dir" rel="nofollow">Contact Peter McCarthy</a>
              </li>
              <li id="add-to-network">
                <a href="http://www.linkedin.com/ppl/webprofile?action=ctu&amp;id=12104394&amp;pvs=pp&amp;authToken=OCTl&amp;authType=name&amp;trk=ppro_getintr&amp;lnk=cnt_dir" rel="nofollow">Add Peter McCarthy to your network</a>
              </li>
            </ul>
          </div>
        </div>
      </div>
    </div>
  <div id="main">
        <div id="overview">
          <dl>
              <dt>Past</dt>
              <dd>
                <ul>
                        <li>




            
      Development Team Leader, Cardiovascular, Metabolic and Endocrine Diseases
    
        at
            <a href="http://www.linkedin.com/companies/pfizer" >Pfizer</a>

                        </li>
                        <li>




            
      Research Team Leader, Cardiovascular, Metabolic &amp; Endocrine Diseases
    
        at
            <a href="http://www.linkedin.com/companies/pfizer" >Pfizer</a>

                        </li>
                        <li>




            
      Vice President, Head of Discovery Operations, Groton Discovery
    
        at
            <a href="http://www.linkedin.com/companies/pfizer" >Pfizer</a>

                        </li>
                </ul>
                  <div class="showhide-block" id="morepast">
                    <ul>
                            <li>




            
      Vice President, Zone Head Antibacterials, Immunology &amp; Inflammation Discovery
    
        at
            <a href="http://www.linkedin.com/companies/pfizer" >Pfizer</a>

                            </li>
                            <li>




            
      Sr Executive Director, Zone Head, Respiratory, Allergy, Immunology, Inflammation &amp; Infectious Diseas
    
        at
            <a href="http://www.linkedin.com/companies/pfizer" >Pfizer</a>

                            </li>
                            <li>




            
      Group Director, Head of Medicinal Chemistry, Cardiovascular and Metabolic Diseases Discovery
    
        at
            <a href="http://www.linkedin.com/companies/pfizer" >Pfizer</a>

                            </li>
                            <li>




            
      Assistant Director, Medicinal Chemistry, Cardiovascular and Metabolic Diseases Discovery
    
        at
            <a href="http://www.linkedin.com/companies/pfizer" >Pfizer</a>

                            </li>
                            <li>




            
      Research Scientist ---&gt; Sr. Research Investigator, Medicinal Chemistry, Discovery Research
    
        at
            <a href="http://www.linkedin.com/companies/pfizer" >Pfizer</a>

                            </li>
                    </ul>
                    <p class="seeall showhide-link"><a href="#" id="morepast-hide">see less...</a></p>
                  </div>
                      <p class="seeall showhide-link"><a href="#" id="morepast-show">5 more...</a></p>
              </dd>
              <dt>Education</dt>
              <dd>
                <ul>
                      <li>
                        
           Massachusetts Institute of Technology
      
                      </li>
                      <li>
                        
           Boston College
      
                      </li>
                </ul>
              </dd>
              <dt class="connections">Connections</dt>
              <dd class="connections">
                <img src="http://static02.linkedin.com/img/icon/conx/icon_conx_16_24x24.gif" width="24" height="24" alt="" />
                <strong class="connection-count">
                204
                </strong> connections
              </dd>

              <dt>Industry</dt>
              <dd>
                Pharmaceuticals
              </dd>
            
          </dl>
        </div>
        <hr />
          <div id="summary">
            <h2>Peter McCarthy&#8217;s Summary</h2>
              <p class="summary">
                A dynamic and energetic organizational leader with multi-national experience in a complex multi-disciplinary environment.  Highly effective at leading teams to utilize and integrate their expertise to fulfill strategic objective.  Accomplished at creating and managing a portfolio of drug projects with consideration of medical, commercial, regulatory, scientific and financial requirements.  Additionally experienced in supervising and developing people, influencing broadly within an organization, and detecting and adapting to changes in the internal and external environment.<br>
<br>
&#x2022;  20 years experience in drug discovery.<br>
&#x2022;  12 years experience in drug development (preclinical thru Phase II).<br>
&#x2022;  Therapeutic area leadership experience in obesity, diabetes, osteoporosis, atherosclerosis, cardiovascular, frailty, inflammation, immunology, oncology, antibacterials, and respiratory diseases.<br>
&#x2022;  Experience in discovery and development of small molecules, antibodies, and protein therapeutics.<br>
&#x2022;  Well-versed in all allied disciplines including chemistry, pharmacology, molecular genetics, drug metabolism, pharmaceutical sciences, safety evaluation, regulatory affairs, and clinical sciences.<br>
&#x2022;  17 publications, 13 patents and 10 scientific presentations.<br>
&#x2022;  Extensive involvement with IND submissions and regulatory interactions.<br>
&#x2022;  Extensive leadership, management and supervisory experience.
              </p>
              <h3>Peter McCarthy&#8217;s Specialties:</h3>
              <p class="skills">
                Drug discovery and preclinical through Phase II development
              </p>
          </div>
          <hr />
          <div id="experience">
            <h2>Peter McCarthy&#8217;s Experience</h2>
            <ul class="vcalendar">



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Development Team Leader, Cardiovascular, Metabolic and Endocrine Diseases
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/pfizer?trk=ppro_cprof&amp;lnk=vw_cprofile" >Pfizer</a></h4>
  <p class="organization-details">(Public Company; PFE; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2007-04-01">April 2007</abbr>
 &mdash; <abbr class="dtend" title="2009-04-01">April 2009</abbr>        <abbr class="duration" title="P2Y1M">(2 years 1 month)</abbr>
  </p>
    <p class="description">Managed worldwide exploratory development portfolios and lead development teams for obesity and osteoporosis.  Responsible for advancing a portfolio of 12 candidates from preclinical to Phase II across 6 mechanisms of action (CB-1 antagonists, 5HT2c agonists, opioid antagonists, MTP inhibitors, CCK-1R antagonists, PEG-PYY protein biologic)<br>
Achievements<br>
&#x2022;  In two years, teams under my leadership completed 2 Phase II programs, 3 Phase I programs, and 6 preclinical programs.<br>
&#x2022;  As team leader, I guided our team through innovative design and execution of a Phase II &#x201c;proof-of-concept&#x201d; studies which saved 10 months and $1.5 MM compared with a standard design.  We studied 252 patients in 7 countries for 3 months with a 1 month &#x201c;go-no-go&#x201d; interim.  We overcame numerous start-up challenges (site selection, study initiation, recruiting) as well as completion challenges (study management, data management, clinical programming), yet managed to complete the study on time and on budget.<br>
&#x2022;  Rapidly and definitively addressed several issues with toxicology (CB-1, CCK-1R), regulatory (CCK-1R, opioid antagonists), drug/device production (opioid antagonist handling, PEG-PYY biologic bulk &amp; injector pen) as well as requests for acceleration (MTP, CaR).<br>
&#x2022;  Worked with select colleagues from research, marketing and commercial to devise new strategic options in the obesity therapeutic area for Pfizer, Inc.  The corporation endorsed the option to shift from a pure obesity focus to a diabetes with weight loss focus, and I led this transition in development.<br>
&#x2022;  Supervised 3-4 Clinicians and 1 Project Manager.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Research Team Leader, Cardiovascular, Metabolic &amp; Endocrine Diseases
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/pfizer?trk=ppro_cprof&amp;lnk=vw_cprofile" >Pfizer</a></h4>
  <p class="organization-details">(Public Company; PFE; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2005-12-01">December 2005</abbr>
 &mdash; <abbr class="dtend" title="2007-04-01">April 2007</abbr>        <abbr class="duration" title="P1Y5M">(1 year 5 months)</abbr>
  </p>
    <p class="description">Managed the worldwide portfolio of preclinical to Phase II drugs for the Cardiovascular, Metabolic and Endocrine Disease therapeutic zone.  Directly led the obesity and osteoporosis areas, and directly supervised the leaders of the cardiovascular, atherosclerosis, diabetes and frailty areas.<br>
Achievements<br>
&#x2022;  Although this organizational structure was only in place for a little more than one year, I led delivery of 2 Phase I and 1 Phase II starts from obesity and osteoporosis, and 8 Phase I and 5 Phase II starts from CVMED Research as a whole.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Vice President, Head of Discovery Operations, Groton Discovery
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/pfizer?trk=ppro_cprof&amp;lnk=vw_cprofile" >Pfizer</a></h4>
  <p class="organization-details">(Public Company; PFE; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2003-07-01">July 2003</abbr>
 &mdash; <abbr class="dtend" title="2005-12-01">December 2005</abbr>        <abbr class="duration" title="P2Y6M">(2 years 6 months)</abbr>
  </p>
    <p class="description">Led a group of senior managers in analyzing our discovery process and recommending avenues for improvement<br>
Achievements<br>
&#x2022;  Built a new business function to provide improved analysis and operation of the overall Groton Discovery portfolio.  Analyses led to decisions on program transitions as well as avenues to reduce development attrition.<br>
&#x2022;  Completely rebuilt Groton Discovery project database, and used this as the basis for building a ProModel-based portfolio simulation tool with which to do scenario testing for strategic planning. <br>
&#x2022;  Other key advances included the development of a cross-Research model for pursuing discovery research, and establishment of communication planning and feedback capabilities to improve colleague engagement. <br>
&#x2022;  As WW Discovery Line Leader for Global Closed Loop Initiative, lead global, cross-line collaboration to improve the hit to CAN process through increased efficiency, lower costs and improved survival of the candidates delivered to development.  Phase 1 of the initiative was highly successful and delivered greatly improved processes, along with accompanying instrumentation and software, to 7 sites throughout the globe. <br>
&#x2022;  As Lead Discovery Representative, Exploratory Development Management Team &amp; Preclinical Development Management Team, made decisions for Discovery on all exploratory development candidates. Also contributed to design and implementation of new exploratory development governance model (single management body, Exploratory Development Directors, single point of accountability from each line) .</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Vice President, Zone Head Antibacterials, Immunology &amp; Inflammation Discovery
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/pfizer?trk=ppro_cprof&amp;lnk=vw_cprofile" >Pfizer</a></h4>
  <p class="organization-details">(Public Company; PFE; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2000-08-01">August 2000</abbr>
 &mdash; <abbr class="dtend" title="2003-07-01">July 2003</abbr>        <abbr class="duration" title="P3Y">(3 years)</abbr>
  </p>
    <p class="description">Managed one hundred and eight-six researchers from three disciplines (medicinal chemistry, biology, and molecular biology) pursuing new drugs in three therapeutic areas.<br>
Achievements<br>
&#x2022;  Delivered eleven candidates or one candidate per 59 FTE-years (global average was one per 135 FTE-years). The average compliance with quality guidelines was 96% (global average was 93%).  Ten of these candidates were still active when I left this position.  This gives a survival rate of 91% (average for other site zones is 38%).  The only attrition suffered (CP-907,699, &#xf062;-lactamase inhibitor) occurred because of budget issues. <br>
&#x2022;  As Chairman of the Inflammation-Immunology Therapeutic Area Team (TAT) and Exploratory Development representative to both the Oncology and Antibacterial TATs, I lead the design of idea to Phase II strategy and achievement of alignment across the global organization which included the acquired Parke Davis organization.  <br>
&#x2022;  As Chairman of the CRAIIID EDMT (Cancer, Respiratory, Allergy, Immunology, Inflammation &amp; Infectious Diseases Exploratory Development Management Team), I managed a portfolio of 18-21 development candidates with an annual budget of $134 MM supported by 332 development scientists.  After turning around the group, the 2003 productivity was outstanding with portfolio delivering 1 Phase III start, 2 Phase II starts, and 5 Phase I starts.<br>
&#x2022;  Contributed to several exploratory development process improvements, especially Exploratory Development Portfolio Management methodology and Quality Stage Gates.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Sr Executive Director, Zone Head, Respiratory, Allergy, Immunology, Inflammation &amp; Infectious Diseas
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/pfizer?trk=ppro_cprof&amp;lnk=vw_cprofile" >Pfizer</a></h4>
  <p class="organization-details">(Public Company; PFE; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="1998-06-01">June 1998</abbr>
 &mdash; <abbr class="dtend" title="2000-08-01">August 2000</abbr>        <abbr class="duration" title="P2Y3M">(2 years 3 months)</abbr>
  </p>
    <p class="description">Respiratory, Allergy, Immunology, Inflammation &amp; Infectious Diseases (RAIIID).  Managed two hundred and ten researchers from four disciplines (medicinal chemistry, biology, molecular biology and drug metabolism) pursuing new drugs in four therapeutic areas.<br>
Achievements<br>
&#x2022;  One of the architects of a complete reorganization of US Discovery in 1998.  Achieved better alignment of research goals and smaller, better integrated operating units with full capabilities to take an idea to a drug candidate. <br>
&#x2022;  When two previous managers had failed to turn this group around, I was hand picked to return this group to productivity.  I diagnosed and repaired problems of goal misalignment, poor portfolio planning, poor communication, and lack of accountability.  In less than two years, this group had gone from worst to best in terms of candidate quantity and quality.<br>
&#x2022;  During this period, the zone produced 9 clinical candidates which demonstrated development survival roughly twice as high as candidates nominated in other parts of WW Discovery.<br>
&#x2022;  Selected to Head the US Chemistry Recruiting Organization which sources and recruits organic chemists for US Discovery, AH Discovery, and US PR&amp;D.  Completely rebuilt this organization which resulted in much faster, efficient and successful recruitment of top talent. <br>
&#x2022;  As Discovery representative to the CRAIIID EDMT (Cancer, Respiratory, Allergy, Immunology, Inflammation &amp; Infectious Diseases Exploratory Development Management Team), managed a portfolio of 14-16 drugs from preclinical thru Phase II.  Adapted the Discovery portfolio management tool to Exploratory Development and implemented its use.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Group Director, Head of Medicinal Chemistry, Cardiovascular and Metabolic Diseases Discovery
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/pfizer?trk=ppro_cprof&amp;lnk=vw_cprofile" >Pfizer</a></h4>
  <p class="organization-details">(Public Company; PFE; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="1996-01-01">January 1996</abbr>
 &mdash; <abbr class="dtend" title="1998-05-01">May 1998</abbr>        <abbr class="duration" title="P2Y5M">(2 years 5 months)</abbr>
  </p>
    <p class="description">Led the research of 22-27 medicinal chemistry labs (68-81 researchers) in the execution of multi-project objectives in the atherosclerosis, cardiovascular, diabetes, obesity, osteoporosis and frailty therapy areas.<br>
Achievements<br>
&#x2022;  As Chairman of Portfolio Management 1998 (PM&#x2019;98) Methodology Subcommittee, led the design and refinement of PM&#x2019;98 methodology, a multi-attribute portfolio optimization tool which, with refinements, was used for 12 years to guide global decisions on portfolio composition and resource investments. <br>
&#x2022;  Led development and initiation of successful higher speed chemistry methodologies within CVMD.  This initiative bridged the gap between plate-based chemistry and classical medicinal chemistry, thereby increase the per chemist productivity of the zone. <br>
&#x2022;  As Co-Chairman of the NPY Steering Committee Member, successfully led a collaboration with Neurogen Corporation which advanced NPY candidates into clinical evaluation.<br>
&#x2022;  Member of US Discovery Research Committee and worldwide Discovery Management Committee overseeing all discovery research for Pfizer.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Assistant Director, Medicinal Chemistry, Cardiovascular and Metabolic Diseases Discovery
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/pfizer?trk=ppro_cprof&amp;lnk=vw_cprofile" >Pfizer</a></h4>
  <p class="organization-details">(Public Company; PFE; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="1991-06-01">June 1991</abbr>
 &mdash; <abbr class="dtend" title="1996-01-01">January 1996</abbr>        <abbr class="duration" title="P4Y8M">(4 years 8 months)</abbr>
  </p>
    <p class="description">Led research of 6-15 medicinal chemistry labs (20-45 chemists) in the execution of multi-project objectives in the atherosclerosis, diabetes, obesity and osteoporosis therapy areas.<br>
Achievements<br>
&#x2022;  Delivered 9 candidates for clinical development in 5 years from my groups, including direct invention of a cholesterol absorption inhibitor that was advanced to Phase II.<br>
&#x2022;  Brought in to turn around the low productivity of the diabetes, obesity and osteoporosis teams, and in less than a year, all three teams had produced novel prototype candidates. <br>
&#x2022;  Medicinal chemistry representative on early candidate management teams overseeing development of ACAT inhibitors, cholesterol absorption inhibitors, glycogen phosphorylase inhibitors, and NPY antagonist.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Research Scientist ---&gt; Sr. Research Investigator, Medicinal Chemistry, Discovery Research
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/pfizer?trk=ppro_cprof&amp;lnk=vw_cprofile" >Pfizer</a></h4>
  <p class="organization-details">(Public Company; PFE; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="1984-12-01">December 1984</abbr>
 &mdash; <abbr class="dtend" title="1991-06-01">June 1991</abbr>        <abbr class="duration" title="P6Y7M">(6 years 7 months)</abbr>
  </p>
    <p class="description">Supervised a medicinal chemistry laboratory of 2-5 chemists in the design in synthesis of potential new drugs for atherosclerosis and gastrointestinal diseases.  Transitioned into role of project coordinator of all medicinal chemistry labs on each project.  <br>
Achievements<br>
&#x2022;  Inventor of two H+K+-ATPase inhibitors and one ACAT inhibitor candidates that were advanced into clinical development.<br>
&#x2022;  Identified and championed licensing of two bile acid sequestrant candidates and one cholesterol absorption inhibitor candidate.</p>
</li>
            </ul>
          </div>
          <hr />
          <div id="education">
            <h2>Peter McCarthy&#8217;s Education</h2>
            <ul class="vcalendar">


	<li class="education vevent vcard">
    <h3 class="summary fn org">
           Massachusetts Institute of Technology
      </h3>
		<div class="description">
    <p>
      <span class="degree">Ph.D.</span>
        , 
      <span class="major">Organic Chemistry</span>
      , 
          <abbr class="dtstart" title="1980-01-01">1980</abbr> &mdash; <abbr class="dtend" title="1985-12-31">1985</abbr> 
    </p>
      <p class="notes">Investigated new methods for asymmetric synthesis and their application to the synthesis of macrolide natural products.  Thesis title:  &quot;Aldol Methodology in Macrolide Synthesis:  Toward a Total Synthesis of Streptovaricin A.&quot;  Thesis advisor:  Professor Satoru Masamune.<br>
<br>
John A. Lyons Fellow (1981-1984)</p>
		</div>
  </li>


	<li class="education vevent vcard">
    <h3 class="summary fn org">
           Boston College
      </h3>
		<div class="description">
    <p>
      <span class="degree">B.S.</span>
        , 
      <span class="major">Chemstry</span>
      , 
          <abbr class="dtstart" title="1976-01-01">1976</abbr> &mdash; <abbr class="dtend" title="1980-12-31">1980</abbr> 
    </p>
      <p class="notes">graduated summa cum laude (top 3%)<br>
<br>
Phi Beta Kappa (inducted 1980)<br>
Alpha Sigma Nu (inducted 1979)<br>
Scholar of the College (1980)</p>
		</div>
  </li>
            </ul>
          </div>
          <hr />
          <div id="additional-information">
            <h2>Additional Information</h2>
              <h3>Peter McCarthy&#8217;s Interests:</h3>
              <p class="interests">cycling, ice hockey,</p>
              <h3>Peter McCarthy&#8217;s Groups:</h3>
              <ul>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=36798&amp;sharedKey=70943A1BBBDB" >          <img src="http://media.linkedin.com/media/p/3/000/000/2e9/25eda91.png" width="60" height="30" alt="Lifesciences Opportunities in US" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Lifesciences Opportunities in US</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=42466&amp;sharedKey=048C7E4A25AC" >          <img src="http://media.linkedin.com/media/p/1/000/001/36d/37f393c.png" width="60" height="30" alt="Pfizer Alumni" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Pfizer Alumni</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=46688&amp;sharedKey=2BF06D5AA778" >          <img src="http://media.linkedin.com/media/p/1/000/002/389/12b602e.png" width="60" height="30" alt="Boston College Alumni Group" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Boston College Alumni Group</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=60035&amp;sharedKey=378558122A75" >          <img src="http://media.linkedin.com/media/p/1/000/00e/357/24afaec.png" width="60" height="30" alt="Biotech &amp; Pharma Professionals Network" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Biotech &amp; Pharma Professionals Network</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=61144&amp;sharedKey=50805F11DA80" >          <img src="http://media.linkedin.com/media/p/1/000/011/110/3929162.png" width="60" height="30" alt="ex-Pfizer Employee (~5000 members)" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">ex-Pfizer Employee (~5000 members)</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=61852&amp;sharedKey=4A6C9B2DF6EC" >          <img src="http://media.linkedin.com/media/p/1/000/009/095/389a39f.png" width="60" height="30" alt="Professionals in Pharmaceutical Industry and Biotech Industry" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Professionals in Pharmaceutical Industry and Biotech Industry</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=69586&amp;sharedKey=3B42CC3043BC" >          <img src="http://media.linkedin.com/media/p/3/000/020/25e/3c92326.png" width="60" height="30" alt="MIT Massachusetts Institute of Technology Alumni" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">MIT Massachusetts Institute of Technology Alumni</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=87134&amp;sharedKey=13C148789DDB" >          <img src="http://media.linkedin.com/media/p/3/000/017/06a/2c51e08.png" width="60" height="30" alt="Biotechnology/Pharmaceuticals" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Biotechnology/Pharmaceuticals</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=156336&amp;sharedKey=138F4502E0A2" >          <img src="http://media.linkedin.com/media/p/2/000/00d/351/09a8da9.png" width="60" height="30" alt="Healthcare Executive.net" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Healthcare Executive.net</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1774369&amp;sharedKey=746929748C0D" >          <img src="http://media.linkedin.com/media/p/3/000/01b/1f5/161a3bf.png" width="60" height="30" alt="E-Recruitment Group (Post Jobs) (Post Resumes) Concept by Group of Sr. Recruiters" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">E-Recruitment Group (Post Jobs) (Post Resumes) Concept by Group of Sr. Recruiters</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1828751&amp;sharedKey=09796703FF3B" >          <img src="/img/groups/default/default_small.gif" width="60" height="30" alt="Jobs in Pharma and Biotech Industries" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Jobs in Pharma and Biotech Industries</span> </li>
              </ul>
          </div>
          <hr />
      <div id="contact-settings">
        <h2>Peter McCarthy&#8217;s Contact Settings</h2>
        <h3>Interested In:</h3>
        <ul>
            <li>
              career opportunities
            </li>
            <li>
              consulting offers
            </li>
            <li>
              expertise requests
            </li>
            <li>
              business deals
            </li>
            <li>
              reference requests
            </li>
            <li>
              getting back in touch
            </li>
        </ul>
      </div>
      <hr />
      <div class="viewfull">
        <p><a href="http://www.linkedin.com/ppl/webprofile?action=vmi&id=12104394&pvs=pp&authToken=OCTl&authType=name&trk=ppro_viewmore&lnk=vw_pprofile" class="action" rel="nofollow"><span>View Full Profile</span></a></p>
      </div>
  </div>
  <div id="control" class="infobar">
    <div class="powered">
      <h3> Public profile powered by: <a href="http://www.linkedin.com/home?trk=ppro_pbli" ><img src="http://static01.linkedin.com/img/logos/logo_82x23.png" height="23" width="82" alt="LinkedIn" /></a>
      </h3>
      <p>Create a public profile: <strong>
        <a href="http://www.linkedin.com/ppl/webprofile?action=gwp&id=12104394&pvs=pp&authToken=OCTl&authType=name&trk=ppro_geturl&lnk=sign_in" rel="nofollow">Sign In</a>
        </strong> or <strong>
        <a href="http://www.linkedin.com/ppl/webprofile?action=gwp&id=12104394&pvs=pp&authToken=OCTl&authType=name&trk=ppro_joinnow&lnk=join_now" rel="nofollow">Join Now</a>
        </strong></p>
    </div>
      <div class="box" id="readmore">
        <div class="title">
          <h3>View Peter McCarthy&#8217;s full profile:</h3>
        </div>
        <div class="content">
          <ul>
            <li>See who you and <strong>Peter McCarthy</strong> know in common</li>
            <li>Get introduced to <strong>Peter McCarthy</strong></li>
            <li>Contact <strong>Peter McCarthy</strong> directly</li>
          </ul>
          <p class="btn">
            <a href="http://www.linkedin.com/ppl/webprofile?action=vmi&id=12104394&pvs=pp&authToken=OCTl&authType=name&trk=ppro_viewmore&lnk=vw_pprofile" class="action" rel="nofollow"><span>View Full Profile</span></a>
          </p>
        </div>
      </div>
    
    
    <div class="box" id="search">
      <div class="title">
        <h3><strong>Name Search:</strong></h3>
      </div>
      <div class="content">
        <p><strong>Search for people you know</strong> from over 45 million professionals already on LinkedIn.</p>
        <form name="searchForm" action="/pub/dir/" method="get">
          <p class="field"><span class="lbl">
            <label for="first">First Name</label>
            <br />
            </span>
            <input type="text" name="first" id="first" />
            &nbsp;&nbsp;<span class="lbl"><br />
            <label for="last">Last Name</label>
            <br />
            </span>
            <input type="text" name="last" id="last" />
          </p>
          <p class="example">
            <input class="btn-secondary" type="submit" name="search" value="Search"/> (example: <strong>
<a href="http://www.linkedin.com/pub/dir/Peter/McCarthy/?trk=ppro_find_others" >Peter McCarthy</a></strong>)
          </p>
        </form>
      </div>
    </div>

    
    <script type="text/javascript">
      var dbl_page = 'public_profile';
    </script>
    
      <script type="text/javascript" src="http://static.linkedin.com/scds/pprofile/build-499_4_2302-prod/js/ads.js"></script>
    
      <script type="text/javascript">
      /* <![CDATA[ */
      var google_keywords = null, google_ad_client = 'pub-2283433109277150', google_ad_width = 300, google_ad_height = 250, google_ad_format = '300x250_as';
        var dbl_src = "http://ad.doubleclick.net/adj/linkedin.dart/" + dbl_page + ";;tile=1;dcopt=ist;sz=300x250;" + encodeURIComponent('extra=null') + ";ord=" + Math.random() * 10000000000000000 +"?";
        document.write('<script src="' + dbl_src + '" type="text/javascript"><\/script>');
      /* ]]> */
      </script>
  </div>
</div>
<hr />






    <div id="footer" class="guest">
      <div id="directory">
        <h3>People directory:</h3>
        <ol type="a">
          <li><a href="http://www.linkedin.com/directory/people/a.html" >A</a></li>
          <li><a href="http://www.linkedin.com/directory/people/b.html" >B</a></li>
          <li><a href="http://www.linkedin.com/directory/people/c.html" >C</a></li>
          <li><a href="http://www.linkedin.com/directory/people/d.html" >D</a></li>
          <li><a href="http://www.linkedin.com/directory/people/e.html" >E</a></li>
          <li><a href="http://www.linkedin.com/directory/people/f.html" >F</a></li>
          <li><a href="http://www.linkedin.com/directory/people/g.html" >G</a></li>
          <li><a href="http://www.linkedin.com/directory/people/h.html" >H</a></li>
          <li><a href="http://www.linkedin.com/directory/people/i.html" >I</a></li>
          <li><a href="http://www.linkedin.com/directory/people/j.html" >J</a></li>
          <li><a href="http://www.linkedin.com/directory/people/k.html" >K</a></li>
          <li><a href="http://www.linkedin.com/directory/people/l.html" >L</a></li>
          <li><a href="http://www.linkedin.com/directory/people/m.html" >M</a></li>
          <li><a href="http://www.linkedin.com/directory/people/n.html" >N</a></li>
          <li><a href="http://www.linkedin.com/directory/people/o.html" >O</a></li>
          <li><a href="http://www.linkedin.com/directory/people/p.html" >P</a></li>
          <li><a href="http://www.linkedin.com/directory/people/q.html" >Q</a></li>
          <li><a href="http://www.linkedin.com/directory/people/r.html" >R</a></li>
          <li><a href="http://www.linkedin.com/directory/people/s.html" >S</a></li>
          <li><a href="http://www.linkedin.com/directory/people/t.html" >T</a></li>
          <li><a href="http://www.linkedin.com/directory/people/u.html" >U</a></li>
          <li><a href="http://www.linkedin.com/directory/people/v.html" >V</a></li>
          <li><a href="http://www.linkedin.com/directory/people/w.html" >W</a></li>
          <li><a href="http://www.linkedin.com/directory/people/x.html" >X</a></li>
          <li><a href="http://www.linkedin.com/directory/people/y.html" >Y</a></li>
          <li><a href="http://www.linkedin.com/directory/people/z.html" >Z</a></li>
          <li type="disc"><a href="http://www.linkedin.com/directory/people/@.html" >more</a></li>
        </ol>
      </div>

      <ul> 
        <li class="first"><a href="http://press.linkedin.com/" rel="nofollow">About LinkedIn</a></li>
        <li><a href="http://www.linkedin.com/static?key=privacy_policy" rel="nofollow">Privacy Policy</a></li>
        <li><a href="http://linkedin.custhelp.com/" rel="nofollow">Help &amp; <acronym title="Frequently Asked Questions">FAQ</acronym></a></li>
        <li><a href="http://talent.linkedin.com/?pin=tr01" >Recruiting Solutions</a></li>
        <li><a href="http://www.linkedin.com/static?key=advertising_info" rel="nofollow">Advertising</a></li>
      </ul>
      <p>Copyright &copy; 2009 LinkedIn Corporation. All rights reserved.</p>
      <p class="terms">Use of this site is subject to express <a href="http://www.linkedin.com/static?key=user_agreement" rel="nofollow">terms of use</a>, which prohibit commercial use of this site.<br />By continuing past this page, you agree to abide by these terms.</p>
    </div>
    

      <script type="text/javascript" src="http://static.linkedin.com/scds/pprofile/build-499_4_2302-prod/js/cookies.js"></script>
     
<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
var pageTracker = _gat._getTracker("UA-3242811-1");
pageTracker._initData();
pageTracker._linkedInMemberCookie = readCookie("visit"); 
pageTracker._linkedInUserType = (pageTracker._linkedInMemberCookie == "M") ? "user" : "guest";  
pageTracker._setVar(pageTracker._linkedInUserType);
pageTracker._trackPageview();
</script>



	




  
  
  
  
  
   

        <script type="text/javascript" src="http://static.linkedin.com/scds/concat/pprofile/build-499_4_2302-prod/js?f=lib%2Fyui%2F2.7.0%2Fyahoo-dom-event%2Fyahoo-dom-event&amp;f=js%2Fcore%2FDefine&amp;f=js%2Futil%2FHelps&amp;f=js%2Fpublic_profile&amp;f=js%2Fshowhide&amp;f=js%2Fcookies"></script>
    
<script type="text/javascript">
/* <![CDATA[ */
  if(typeof(i18n) == 'undefined') var i18n = {}; 
  i18n.TEXT_PLEASE_ENTER = "Please enter a first and last name.";
  showHide.init();

  var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
  document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
/* ]]> */
</script>
<script type="text/javascript">
/* <![CDATA[ */
var pageTracker = _gat._getTracker("UA-3242811-1");
pageTracker._initData();
pageTracker._linkedInMemberCookie = readCookie("visit"); 
pageTracker._linkedInUserType = (pageTracker._linkedInMemberCookie == "M") ? "user" : "guest";  
pageTracker._setVar(pageTracker._linkedInUserType);

    pageTracker._trackPageview("control_profiles");    
/* ]]> */
</script>


<script type="text/javascript" src="http://edge.quantserve.com/quant.js"></script> 
<noscript> 
  <a href="http://www.quantcast.com/p-b3sGjMtCFrexE" target="_blank"><img src="http://pixel.quantserve.com/pixel/p-b3sGjMtCFrexE.gif" style="display: none;" border="0" height="1" width="1" alt="Quantcast" /></a> 
</noscript>



<script type="text/javascript" src="http://b.scorecardresearch.com/beacon.js"></script> 
<script type="text/javascript">
  COMSCORE.beacon({ c1:2, c2:6402952, c3:"", c4:"", c5:"", c6:"", c15:"" });
</script>
<noscript> 
  <img src="http://b.scorecardresearch.com/b?c1=2&amp;c2=6402952&amp;c3=&amp;c4=&amp;c5=&amp;c6=&amp;c15=&amp;cv=1.3&amp;cj=1" style="display:none" width="0" height="0" alt="" />
</noscript>



</body>
</html>

